[HTML][HTML] A treat-to-target update in ulcerative colitis: a systematic review

R Ungaro, JF Colombel, T Lissoos… - Official journal of the …, 2019 - journals.lww.com
OBJECTIVES: In 2015, the Selecting Therapeutic Targets in Inflammatory Bowel Disease
(STRIDE) program proposed shifting the therapeutic focus on ulcerative colitis (UC) toward …

An update on inflammatory bowel disease

T Sairenji, KL Collins, DV Evans - Primary Care: Clinics …, 2017 - primarycare.theclinics.com
An Update on Inflammatory Bowel Disease - Primary Care: Clinics in Office Practice Skip to
Main Content Advertisement Primary Care: Clinics in Office Practice Log in Register Log in …

Selecting end points for disease-modification trials in inflammatory bowel disease: the SPIRIT consensus from the IOIBD

C Le Berre, L Peyrin-Biroulet, WJ Sandborn… - Gastroenterology, 2021 - Elsevier
Background and Aims Inflammatory bowel diseases (IBD), encompassing Crohn's disease
(CD) and ulcerative colitis (UC), are chronic and disabling disorders. Prospective disease …

Incidence and treatment of patients diagnosed with inflammatory bowel diseases at 60 years or older in Sweden

ÅH Everhov, J Halfvarson, P Myrelid, MC Sachs… - Gastroenterology, 2018 - Elsevier
Background & Aims Diagnosis of inflammatory bowel diseases (IBD) is increasing among
elderly persons (60 years or older). We performed a nationwide population-based study to …

Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study

D Pugliese, G Privitera, F Crispino… - Alimentary …, 2022 - Wiley Online Library
Background Vedolizumab registration trials were the first to include elderly patients with
moderate‐to‐severe ulcerative colitis (UC) or Crohn's disease (CD), but few real‐life data …

Intestinal fibrosis

MV Lenti, A Di Sabatino - Molecular aspects of medicine, 2019 - Elsevier
Extensive tissue fibrosis is the end-stage process of a number of chronic conditions affecting
the gastrointestinal tract, including inflammatory bowel disease (Crohn's disease, ulcerative …

Bonferroni-Holm and permutation tests to compare health data: methodological and applicative issues

M Giacalone, Z Agata, PC Cozzucoli… - BMC medical research …, 2018 - Springer
Background Statistical methodology is a powerful tool in the health research; however, there
is wide accord that statistical methodologies are not usually used properly. In particular …

Patients with elderly onset inflammatory bowel disease have a decreased chance of initiation of all types of medications and increased risk of surgeries—A nationwide …

BM Nørgård, FD Zegers, T Knudsen… - Alimentary …, 2023 - Wiley Online Library
Objective In patients with elderly (≥ 60 years) onset inflammatory bowel disease (IBD), we
studied initiation of medications, drug persistency and surgeries. Design A nationwide …

Ulcerative colitis in adulthood and in older patients: same disease, same outcome, same risks?

W Fries, MG Demarzo, G Navarra, A Viola - Drugs & Aging, 2022 - Springer
The number of patients with inflammatory bowel disease (IBD) approaching an older age,
together with the number of over-60-year-old patients newly diagnosed with IBD, is steadily …

Elderly-onset vs adult-onset ulcerative colitis: a different natural history?

I Zammarchi, F Lanzarotto, R Cannatelli, F Munari… - BMC …, 2020 - Springer
Background Incidence of ulcerative colitis (UC) in elderly population is increasing because
of ageing and because of its minimal impact on life span. Data on natural history, outcomes …